These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8429119)

  • 1. The safety of ranitidine in elderly versus non-elderly patients.
    Sirgo MA; Mills R; Euler AR; Walker S
    J Clin Pharmacol; 1993 Jan; 33(1):79-83. PubMed ID: 8429119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lansoprazole compared with ranitidine for the treatment of nonerosive gastroesophageal reflux disease.
    Richter JE; Campbell DR; Kahrilas PJ; Huang B; Fludas C
    Arch Intern Med; 2000 Jun; 160(12):1803-9. PubMed ID: 10871974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of pantoprazole versus ranitidine in the treatment of patients with symptomatic gastroesophageal reflux disease.
    van Zyl J; van Rensburg C; Vieweg W; Fischer R
    Digestion; 2004; 70(1):61-9. PubMed ID: 15297779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rabeprazole: a review of its use in acid-related gastrointestinal disorders.
    Langtry HD; Markham A
    Drugs; 1999 Oct; 58(4):725-42. PubMed ID: 10551440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of acid-related diseases of the gastrointestinal tract. Observations in patients receiving a single evening dose of 300 mg ranitidine].
    Sewing KF; Franz E
    Fortschr Med; 1992 Mar; 110(7):114-6. PubMed ID: 1559647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Onset of relief of symptoms of gastroesophageal reflux disease: post hoc analysis of two previously published studies comparing pantoprazole 20 mg once daily with nizatidine or ranitidine 150 mg twice daily.
    Haag S; Holtmann G
    Clin Ther; 2010 Apr; 32(4):678-90. PubMed ID: 20435237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and tolerability of pantoprazole versus ranitidine in the treatment of reflux esophagitis and the influence of Helicobacter pylori infection on healing rate.
    Meneghelli UG; Boaventura S; Moraes-Filho JP; Leitão O; Ferrari AP; Almeida JR; Magalhães AF; Castro LP; Haddad MT; Tolentino M; Jorge JL; Silva E; Maguilnik I; Fischer R
    Dis Esophagus; 2002; 15(1):50-6. PubMed ID: 12060043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A single nighttime dose of ranitidine 300 mg versus ranitidine 150 mg twice daily in the acute treatment of duodenal ulcer: a European multicenter trial.
    Simon B; Bianchi Porro G; Cremer M; Dobrilla G; Haglund U; Dunn SL; Summers K
    J Clin Gastroenterol; 1986 Jun; 8(3 Pt 2):367-70. PubMed ID: 3531309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute treatment of duodenal ulcer: a multicentre study to compare ranitidine 150 mg twice daily with ranitidine 300 mg once at night.
    Lee FI; Reed PI; Crowe JP; McIsaac RL; Wood JR
    Gut; 1986 Sep; 27(9):1091-5. PubMed ID: 3530897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of gastric ulcer with ranitidine: comparison of a single 300 mg dose at night with 150 mg twice a day].
    Massuda HK; Bettarello A; Eisig JN; Chinzon D; Zaterka S
    Rev Hosp Clin Fac Med Sao Paulo; 1989; 44(5):181-4. PubMed ID: 2700102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of benign chronic gastric ulcer with ranitidine. A randomized, double-blind, and placebo-controlled six week trial.
    Hirschowitz BI; DeLuca V; Graham D; Lorber S; Bright-Asare P; Katon R
    J Clin Gastroenterol; 1986 Jun; 8(3 Pt 2):371-6. PubMed ID: 3531310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Problems associated with medical treatment of peptic ulcer disease.
    Zimmerman TW
    Am J Med; 1984 Nov; 77(5B):51-6. PubMed ID: 6095662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy.
    Sontag SJ; Kogut DG; Fleischmann R; Campbell DR; Richter J; Robinson M; McFarland M; Sabesin S; Lehman GA; Castell D
    Am J Gastroenterol; 1997 Mar; 92(3):429-37. PubMed ID: 9068463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ulcer healing after treatment with sucralfate emulsion or ranitidine. Randomized controlled study in peptic ulcer disease.
    Lykkegaard Nielsen MC; Vagn Nielsen O; Moesgaard F
    J Clin Gastroenterol; 1988 Aug; 10(4):377-9. PubMed ID: 3047220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dyspepsia: incidence of a non-ulcer disease in a controlled trial of ranitidine in general practice.
    Saunders JH; Oliver RJ; Higson DL
    Br Med J (Clin Res Ed); 1986 Mar; 292(6521):665-8. PubMed ID: 3081221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results of the United States ranitidine maintenance trials.
    Silvis SE
    Am J Med; 1984 Nov; 77(5B):33-8. PubMed ID: 6095659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pantoprazole. A review of its pharmacological properties and therapeutic use in acid-related disorders.
    Fitton A; Wiseman L
    Drugs; 1996 Mar; 51(3):460-82. PubMed ID: 8882382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative tolerability profile of omeprazole in clinical trials.
    Simon TJ; Bradstreet DC
    Dig Dis Sci; 1991 Oct; 36(10):1384-9. PubMed ID: 1914759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety profile of Lansoprazole: the US clinical trial experience.
    Freston JW; Rose PA; Heller CA; Haber M; Jennings D
    Drug Saf; 1999 Feb; 20(2):195-205. PubMed ID: 10082075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ranitidine in children with peptic ulcer and patients with pancreatic cystic fibrosis.
    Scorza A; Conti-Nibali S; Sferlazzas C; Saitta G; Tedeschi A
    Int J Clin Pharmacol Res; 1990; 10(3):179-82. PubMed ID: 2228343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.